eccogene glp-1

eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases AZD5004

Name: eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases AZD5004
Brand: hrexcellencemena.com
SKU: 48504002796
Price: 20.61 USD
Availability: InStock
Rating: 4.3627 (15 reviews)

SKU: 48504002796

4.4

EUR20.61 EUR67.61

Pay in 4 interest-free payments of $5.15 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 22 - Oct 27

Description

You might not feel a massive change on day one

eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases AZD5004

Helps the body convert fatty acids into energy to help fuel these vital organs

Abstract: We demonstrated for the first time that a marine-derived antimicrobial peptide (AMP), Sph_12-38, exhibit high antimicrobial activity against P